Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.
Peter R. Galle(Johannes Gutenberg University Mainz), Laura Runkel(Heidelberg University), Wolfgang Stremmel(University Hospital Heidelberg), Henning Walczak(CRUK Lung Cancer Centre of Excellence), Walter Hofmann, Heinz Schaller(Heidelberg University), G. Otto(Heidelberg University), Peter H. Krammer(Slovak Academy of Sciences)
Cited by 700
Related Papers
FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex
|Cell|1996|3.1k
Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor.
|The EMBO Journal|1995|2.2k
Death and anti-death: tumour resistance to apoptosis
|Nature reviews. Cancer|2002|2.1k
Simplified criteria for the diagnosis of autoimmune hepatitis†
|Hepatology|2008|1.9k
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
|Science|1989|1.7k